Paolo Gattuso to Receptor, ErbB-2
This is a "connection" page, showing publications Paolo Gattuso has written about Receptor, ErbB-2.
Connection Strength
0.858
-
Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma. Appl Immunohistochem Mol Morphol. 2003 Jun; 11(2):120-4.
Score: 0.221
-
Non-human-papillomavirus-related malignancies of the vulva: A clinicopathological study. J Cutan Pathol. 2020 Oct; 47(10):917-922.
Score: 0.181
-
Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer. Acta Cytol. 2017; 61(2):140-144.
Score: 0.143
-
Prognostic Value of Coexisting Lobular Carcinoma In Situ With Invasive Lobular Carcinoma. Appl Immunohistochem Mol Morphol. 2016 Nov/Dec; 24(10):738-743.
Score: 0.140
-
The challenging estrogen receptor-negative/ progesterone receptor-negative/HER-2-negative patient: a promising candidate for epidermal growth factor receptor-targeted therapy? Breast J. 2006 Jul-Aug; 12(4):360-2.
Score: 0.068
-
Status of HER-2 in male and female breast carcinoma. Am J Surg. 2001 Oct; 182(4):389-92.
Score: 0.049
-
Low-stage carcinoma of the male breast. A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma. Am J Clin Pathol. 1999 Jan; 111(1):59-69.
Score: 0.041
-
The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries. Hum Pathol. 2005 May; 36(5):536-45.
Score: 0.016